Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “R/R B-NHL”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Early research (Phase 1)Looking for participantsNCT05741359
What this trial is testing

The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Bioray Laboratories 18
Early research (Phase 1)UnknownNCT05453669
What this trial is testing

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Genmab 264
Testing effectiveness (Phase 2)Study completedNCT00992446
What this trial is testing

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Looking for participantsNCT05098613
What this trial is testing

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Who this might be right for
Non-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more
University of Colorado, Denver 68
Testing effectiveness (Phase 2)Looking for participantsNCT06526793
What this trial is testing

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Who this might be right for
B-cell Non-Hodgkin LymphomaFollicular Lymphoma (FL)Large B-Cell Lymphoma (LBCL)
AstraZeneca 270
Testing effectiveness (Phase 2)Looking for participantsNCT07365306
What this trial is testing

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Primary Mediastinal Large B-Cell Lymphoma+5 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03505762
What this trial is testing

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)Looking for participantsNCT06321289
What this trial is testing

Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Chinese PLA General Hospital 30
Early research (Phase 1)Ended earlyNCT05515406
What this trial is testing

Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Ono Pharmaceutical Co., Ltd. 9
Early research (Phase 1)UnknownNCT05535673
What this trial is testing

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Who this might be right for
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
Zhengzhou University 15
Early research (Phase 1)Active Not RecruitingNCT06251180
What this trial is testing

Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD. 112
Very early researchLooking for participantsNCT06716164
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Zhejiang University 36
Large-scale testing (Phase 3)UnknownNCT05466318
What this trial is testing

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell
Sichuan University 306
Large-scale testing (Phase 3)Study completedNCT01321541
What this trial is testing

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Who this might be right for
Diffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more
CTI BioPharma 312
Early research (Phase 1)Looking for participantsNCT03666000
What this trial is testing

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
Non-Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia+1 more
Imugene Limited 135
Testing effectiveness (Phase 2)UnknownNCT03778619
What this trial is testing

MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
GC Cell Corporation 9
Testing effectiveness (Phase 2)Ended earlyNCT04809467
What this trial is testing

A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
Incyte Corporation 54
Next Page
43